Therefore, targeting miR-34a-5p-HIF1A pairing (i.e., using miR-34a-5p mimic or HIF1α inhibitor) may serve as an effective molecular strategy to reduce PCa aggressiveness, especially in AA patients. This evidence concerns the gene HIF1A and posterior cortical atrophy.